SavedAdd your journal

Journals / Çocuk ve Gençlik Ruh Sağlığı Dergisi / 2007 / Cilt: 14 - Sayı: 2

Atomoxetine: Effectiveness and Side Effects on Children and Adolescents

Atomoksetin: Çocuk ve Ergenlerdeki Etkinliği ve Yan Etkileri

Yıldız Özlem ÖÇ
Işık KARAKAYA
Çakın Nursen MEMİK
Pages
105–112
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion: Atomoxetine was found to be effective and well tolareted for the treatment of ADHD in children and adolescents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Atomoxetine is a nonstimulan therapeutic alternative drug for treatment of ADHD in children and adolescents.
📊
Key Findings & Data:It has been found 77 reports on atomoxetine were published, but only 30 reports were related to children and adolescents.
💡
Conclusion & Impact:Discussion: Atomoxetine was found to be effective and well tolareted for the treatment of ADHD in children and adolescents.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Ergen · Hiperaktiviteyle beraber dikkat eksikliği bozukluğu · Çocuk

Abstract

Atomoxetine is a nonstimulan therapeutic alternative drug for treatment of ADHD in children and adolescents. The objective of the paper is to review all the published papers on atomoxetine use in children and adolescents. Method: A computarized literature search was conducted to retrieve all reports about the usage, effectiveness and the side effect of atomoxetine in children and adolescents. It has been found 77 reports on atomoxetine were published, but only 30 reports were related to children and adolescents. Atomoxetine is an effective drug in ADHD, in the comorbide conditions the drug also decreases depression, anxiety and tic symptom severity levels. After once-a-day dose symptom relief continues for whole day. Common side effects of atomoxetine include headache, decreased appetite, vomiting, somnolance, and dizziness. Discussion: Atomoxetine was found to be effective and well tolareted for the treatment of ADHD in children and adolescents.

Özet

Amaç: Atomoksetin DEHB'de pslkostlmülanlara alternatif olarak kullanılmaya başlanan stimulan olmayan bir ilaçtır. Bu yazıda atomoksetinin çocuk ve ergenlerdeki kullanımı ile ilgili çalışmalar gözden geçirilmiştir. Yöntem: Pubrned, Ovid ue Proquest arama motorları kullanılarak atomoksetinin çocuk ve ergenlerde klinik kullanımı, etkinliği ve yan etkileri ile ilgili çalışmalar gözden geçirilmiştir. Atomoksetin ile ilgili 77 çalışma saptanmış, 30 yayın çocuk ve ergenlerle ilgili bulunmuştur. Sonuç: Çocuk ve ergenlerde atomoksetinin DEHB tedavisinde etkin bir ilaç olduğu, eştanılı durumlarda DEHB belirtilerinin yanısıra depresyon, anksiyete ve tik belirti şiddetini de azalttığı, günde tek doz kullanım ile etki süresinin akşam saatlerine dek sürdüğü, en sık yan etkilerinin baş ağrısı, iştah azalması, kusma, uyku hali, sinirlilik, halsizlik, baş dönmesi ve dispepsi olduğu bildirilmiştir. Tartışma:Atomoksetin DEHB tedavisinde iyi tolere edilen ve etkin bir ilaç olarak görünmektedir.

🔖

Cite This Article

ÖÇ, Y. Ö., KARAKAYA, I., MEMİK, Ç. N. (2007). Atomoxetine: Effectiveness and Side Effects on Children and Adolescents. Çocuk ve Gençlik Ruh Sağlığı Dergisi, Cilt: 14 - Sayı: 2, 105–112. https://ajindex.com/articles/161596

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Allen AJ, Kurlan RM, Gilbert DL ve ark (2005) Atomoksetin treatment in children and adolescents withADHD and comorbid tic disorders. Neurology 65:1941-1949.
  2. Biederman J, Heilingenstein JH, Faries DE ve ark (2002) efficacy of atomoxetine versus placebo in school-age girls with ADHD. Pediatrics 110(6):e75. Biederman J, Wigal SB, Spencer TJ ve ark (2006) A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention deficit/hyperactivity disorder. Clin Ther 28(2):280-293.
  3. Bymaster FP, Katner JS, Nelson DL ve ark. (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivitydisorder.Neuropsychopharmacology 27: 699-711.
  4. Caballero J, Nahata MC (2003) Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder 25:3065-3083.
  5. Chalon S, Desager JP, DeSante K ve ark (2003) Effect of liver impairment on the pharmacokinetics of atomoxetine and its metabolites. Clin Pharmacol Ther 73:178-191.
  6. Guengerich FP (1995) Human cytochrome P450 enzymes. Cytochrome P450: Structure, Mechanism, and Biochemistry içinde, Ortiz de Montellano PR (ed). New York: Plenum Pres,s:473-535.
  7. Hah M, Chang K (2005) Atomoxetine fort he treatment of ADHD in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 15(6):996-1004.
  8. Hazell P, Zhang S, Wolanczyk T ve ark (2006) Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 15(2):105-110.
  9. Jain U, Hechtman L, Declan Q ve ark (2006)
  10. CADDRA, Canadian ADHD Practice Guidlines. Published by Canadian ADHD Resource Alliance, Toronto, Canada. Jou RJ, Handen BL, Hardan BY (2005) Retrospective assesment of atomoxetine in children and adolescents with pervasive devalopmental disorders. J Child Adolesc Psychopharmacol 15(2):325-330.
  11. Kaplan S, Heiligenstein J, West S ve ark (2004) Efficacy and safety of atomoxetine in childhood attention deficit hyperactivity disorder with comorbid oppositional defiant disorder. J Atten Disord 8(2):45-52.
  12. Kelsey DK, Sumner CR, Casat CD ve ark (2004) Oncedaily atomoksetin treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behaviour. A